Cargando…

Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients

BACKGROUND: Carbon nanotubes (CNTs) are novel materials with considerable potential in many areas related to nanomedicine. However, a major limitation in the development of CNT-based therapeutic nanomaterials is a lack of reliable and reproducible data describing their chemical and structural compos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivanova, Marina V, Lamprecht, Constanze, Loureiro, M Jimena, Huzil, J Torin, Foldvari, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273976/
https://www.ncbi.nlm.nih.gov/pubmed/22334774
http://dx.doi.org/10.2147/IJN.S27442
_version_ 1782222984479506432
author Ivanova, Marina V
Lamprecht, Constanze
Loureiro, M Jimena
Huzil, J Torin
Foldvari, Marianna
author_facet Ivanova, Marina V
Lamprecht, Constanze
Loureiro, M Jimena
Huzil, J Torin
Foldvari, Marianna
author_sort Ivanova, Marina V
collection PubMed
description BACKGROUND: Carbon nanotubes (CNTs) are novel materials with considerable potential in many areas related to nanomedicine. However, a major limitation in the development of CNT-based therapeutic nanomaterials is a lack of reliable and reproducible data describing their chemical and structural composition. Knowledge of properties including purity, structural quality, dispersion state, and concentration are essential before CNTs see widespread use in in vitro and in vivo experiments. In this work, we describe the characterization of several commercially available and two in-house-produced CNT samples and discuss the physicochemical profiles that will support their use in nanomedicine. METHODS: Eighteen single-walled and multi-walled CNT raw materials were characterized using established analytical techniques. Solid CNT powders were analyzed for purity and structural quality using thermogravimetric analysis and Raman spectroscopy. Extinction coefficients for each CNT sample were determined by ultraviolet-visible near infrared absorption spectroscopy. Standard curves for each CNT sample were generated in the 0–5 μg/mL concentration range for dispersions prepared in 1,2-dichlorobenzene. RESULTS: Raman spectroscopy and thermogravimetric analysis results demonstrated that CNT purity and overall quality differed substantially between samples and manufacturer sources, and were not always in agreement with purity levels claimed by suppliers. Absorbance values for individual dispersions were found to have significant variation between individual single-walled CNTs and multi-walled CNTs and sources supplying the same type of CNT. Significant differences (P < 0.01) in extinction coefficients were observed between and within single-walled CNTs (24.9–53.1 mL·cm(−1)·mg(−1)) and multi-walled CNTs (49.0–68.3 mL·cm(−1)·mg(−1)). The results described here suggest a considerable role for impurities and structural inhomogeneities within individual CNT preparations and the resulting spectroscopic properties of their dispersions. CONCLUSION: Raw CNT materials require thorough analytical workup before they can be used as nanoexcipients. This applies especially to the determination of CNT purity, structure, and concentration. The results presented here clearly demonstrate that extinction coefficients must be determined for individual CNT preparations prior to their use.
format Online
Article
Text
id pubmed-3273976
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32739762012-02-14 Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients Ivanova, Marina V Lamprecht, Constanze Loureiro, M Jimena Huzil, J Torin Foldvari, Marianna Int J Nanomedicine Original Research BACKGROUND: Carbon nanotubes (CNTs) are novel materials with considerable potential in many areas related to nanomedicine. However, a major limitation in the development of CNT-based therapeutic nanomaterials is a lack of reliable and reproducible data describing their chemical and structural composition. Knowledge of properties including purity, structural quality, dispersion state, and concentration are essential before CNTs see widespread use in in vitro and in vivo experiments. In this work, we describe the characterization of several commercially available and two in-house-produced CNT samples and discuss the physicochemical profiles that will support their use in nanomedicine. METHODS: Eighteen single-walled and multi-walled CNT raw materials were characterized using established analytical techniques. Solid CNT powders were analyzed for purity and structural quality using thermogravimetric analysis and Raman spectroscopy. Extinction coefficients for each CNT sample were determined by ultraviolet-visible near infrared absorption spectroscopy. Standard curves for each CNT sample were generated in the 0–5 μg/mL concentration range for dispersions prepared in 1,2-dichlorobenzene. RESULTS: Raman spectroscopy and thermogravimetric analysis results demonstrated that CNT purity and overall quality differed substantially between samples and manufacturer sources, and were not always in agreement with purity levels claimed by suppliers. Absorbance values for individual dispersions were found to have significant variation between individual single-walled CNTs and multi-walled CNTs and sources supplying the same type of CNT. Significant differences (P < 0.01) in extinction coefficients were observed between and within single-walled CNTs (24.9–53.1 mL·cm(−1)·mg(−1)) and multi-walled CNTs (49.0–68.3 mL·cm(−1)·mg(−1)). The results described here suggest a considerable role for impurities and structural inhomogeneities within individual CNT preparations and the resulting spectroscopic properties of their dispersions. CONCLUSION: Raw CNT materials require thorough analytical workup before they can be used as nanoexcipients. This applies especially to the determination of CNT purity, structure, and concentration. The results presented here clearly demonstrate that extinction coefficients must be determined for individual CNT preparations prior to their use. Dove Medical Press 2012 2012-01-25 /pmc/articles/PMC3273976/ /pubmed/22334774 http://dx.doi.org/10.2147/IJN.S27442 Text en © 2012 Ivanova et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Ivanova, Marina V
Lamprecht, Constanze
Loureiro, M Jimena
Huzil, J Torin
Foldvari, Marianna
Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients
title Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients
title_full Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients
title_fullStr Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients
title_full_unstemmed Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients
title_short Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients
title_sort pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273976/
https://www.ncbi.nlm.nih.gov/pubmed/22334774
http://dx.doi.org/10.2147/IJN.S27442
work_keys_str_mv AT ivanovamarinav pharmaceuticalcharacterizationofsolidanddispersedcarbonnanotubesasnanoexcipients
AT lamprechtconstanze pharmaceuticalcharacterizationofsolidanddispersedcarbonnanotubesasnanoexcipients
AT loureiromjimena pharmaceuticalcharacterizationofsolidanddispersedcarbonnanotubesasnanoexcipients
AT huziljtorin pharmaceuticalcharacterizationofsolidanddispersedcarbonnanotubesasnanoexcipients
AT foldvarimarianna pharmaceuticalcharacterizationofsolidanddispersedcarbonnanotubesasnanoexcipients